Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas

dc.contributor.authorCarrió, Meritxell
dc.contributor.authorMazuelas, Helena
dc.contributor.authorRichaud-Patin, Yvonne
dc.contributor.authorGel Moreno, Bernat
dc.contributor.authorTerribas, Ernest
dc.contributor.authorRosas, Imma
dc.contributor.authorJimenez Delgado, Senda
dc.contributor.authorBiayna, Josep
dc.contributor.authorVendredy, Leen
dc.contributor.authorBlanco Guillermo, Ignacio
dc.contributor.authorCastellanos, Elisabeth
dc.contributor.authorLázaro García, Conxi
dc.contributor.authorRaya Chamorro, Ángel
dc.contributor.authorSerra Arenas, Eduard,
dc.date.accessioned2020-10-29T13:47:27Z
dc.date.available2020-10-29T13:47:27Z
dc.date.issued2019-02-12
dc.date.updated2020-10-26T09:26:20Z
dc.description.abstractNeurofibromatosis type 1 (NF1) is a tumor predisposition genetic disease caused by mutations in the NF1 tumor suppressor gene. Plexiform neurofibromas (PNFs) are benign Schwann cell (SC) tumors of the peripheral nerve sheath that develop through NF1 inactivation and can progress toward a malignant soft tissue sarcoma. There is a lack of non-perishable model systems to investigate PNF development. We reprogrammed PNF-derived NF1(-/-) cells, descendants from the tumor originating cell. These NF1(-/-)-induced pluripotent stem cells (iPSCs) captured the genomic status of PNFs and were able to differentiate toward neural crest stem cells and further to SCs. iPSC-derived NF1(-/-) SCs exhibited a continuous high proliferation rate, poor myelination ability, and a tendency to form 3D spheres that expressed the same markers as their PNF-derived primary SC counterparts. They represent a valuable model to study and treat PNFs. PNF-derived iPSC lines were banked for making them available.
dc.format.extent15 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid30713041
dc.identifier.pmid30840859
dc.identifier.urihttps://hdl.handle.net/2445/171527
dc.language.isoeng
dc.publisherCell Press
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.stemcr.2019.01.001
dc.relation.ispartofStem Cell Reports, 2019, vol. 12, num. 2, p. 411-426
dc.relation.urihttps://doi.org/10.1016/j.stemcr.2019.01.001
dc.rightscc by-nc-nd (c) Carrió et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationNeurofibromatosi
dc.subject.classificationAntioncogens
dc.subject.otherNeurofibromatosis
dc.subject.otherAntioncogenes
dc.titleReprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
CarrioM.pdf
Mida:
6.5 MB
Format:
Adobe Portable Document Format